General Catalyst Group Management, LLC
Long book
$183.6M
Q1 2026
Positions
12
Top-10 weight
100%
concentration
Last quarter
+24.8%
SPY +14.8%
Turnover
42%
of book per quarter
Strategy in plain words
auto-generated from filingsGeneral Catalyst Group Management, LLC is a concentrated fundamental stock-picker, running a $183.6M US long book across 12 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: SAMSARA INC-CL A, ARRIVENT BIOPHARMA INC, MAZE THERAPEUTICS INC, MAPLEBEAR INC, GITLAB INC-CL A.
Over the last 9 quarters its long book ran on average 8pp per quarter behind the S&P 500, beating the index in 3 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-9.7%
Q2 2024
+36.7%
Q3 2024
-4.2%
Q4 2024
-14.2%
Q1 2025
+11.8%
Q2 2025
-23.6%
Q3 2025
-33.6%
Q4 2025
-19.8%
Q1 2026
+24.8%
Sector allocation
Technology 46%
Healthcare 39%
Services media 15%
Consumer discretionary 1%
Financials 0%
Long book by quarter
What does General Catalyst own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| IOT SAMSARA INC-CL A | Technology | 2.0M | $63.4M | 34.5% | Held |
| AVBP ARRIVENT BIOPHARMA INC | Healthcare | 1.5M | $34.5M | 18.8% | Held |
| MAZE MAZE THERAPEUTICS INC | Healthcare | 1.0M | $30.9M | 16.8% | Held |
| CART MAPLEBEAR INC | Services media | 710.7K | $26.6M | 14.5% | Held |
| GTLB GITLAB INC-CL A | Technology | 921.4K | $19.9M | 10.9% | Held |
| EIKN EIKON THERAPEUTICS INC | Healthcare | 305.2K | $3.2M | 1.8% | New |
| GUTS FRACTYL HEALTH INC | Healthcare | 4.9M | $2.2M | 1.2% | Held |
| LIFE ETHOS TECHNOLOGIES INC CL-A | Financials | 74.2K | $829K | 0.5% | New |
| CPNG COUPANG INC | Consumer discretionary | 36.7K | $692K | 0.4% | New |
| AMZN AMAZON.COM INC | Consumer discretionary | 2.6K | $538K | 0.3% | New |
| META META PLATFORMS INC-CLASS A | Technology | 658 | $376K | 0.2% | New |
| FIG FIGMA INC-CL A | Technology | 14.8K | $314K | 0.2% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 12 | $183.6M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 7 | $221.7M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 8 | $3.04B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 10 | $4.30B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | Apr 16, 2025 | 11 | $887.5M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Jan 23, 2025 | 11 | $1.14B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 6, 2024 | 11 | $1.43B | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 11 | $1.16B | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 10, 2024 | 11 | $1.30B | canonical | SEC ↗ |
Similar funds
Sanders Capital, LLCGATES FOUNDATION TRUSTEAGLE CAPITAL MANAGEMENT LLCWoodbridge Co LtdAlecta Tjanstepension OmsesidigtMubadala Investment Co PJSCH&H International Investment, LLCNewlands Management Operations LLCINVESTOR ABIndependent Franchise Partners LLPPineStone Asset Management Inc.Pentwater Capital Management LP